These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38513817)

  • 1. How spray drying processing and solution composition can affect the mAbs stability in reconstituted solutions for subcutaneous injections. Part II: Exploring each protein stabilizer effect.
    Barcelo-Chong CM; Filipe V; Nakach M; Inês Ré M
    Int J Pharm; 2024 Apr; 655():124014. PubMed ID: 38513817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How spray drying processing and solution composition can affect the mAbs stability in reconstituted solutions for subcutaneous injections. Part I: Contribution of processing stresses against composition.
    Barceló-Chong CM; Filipe V; Nakach M; Ré MI
    Int J Pharm; 2024 Apr; 655():123925. PubMed ID: 38518870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
    Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray drying: Models and pitfalls.
    Batens M; Massant J; Teodorescu B; Van den Mooter G
    Eur J Pharm Biopharm; 2018 Jun; 127():407-422. PubMed ID: 29499299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray-drying: Trehalose/amino acid combinations as reconstitution time reducing and stability improving formulations.
    Massant J; Fleurime S; Batens M; Vanhaerents H; Van den Mooter G
    Eur J Pharm Biopharm; 2020 Nov; 156():131-142. PubMed ID: 32882422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tableting behavior of freeze and spray-dried excipients in pharmaceutical formulations.
    Madi C; Hsein H; Busignies V; Tchoreloff P; Mazel V
    Int J Pharm; 2024 May; 656():124059. PubMed ID: 38552753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spray-Dried Monoclonal Antibody Suspension for High-Concentration and Low-Viscosity Subcutaneous Injection.
    Huang C; Chen L; Franzen L; Anderski J; Qian F
    Mol Pharm; 2022 May; 19(5):1505-1514. PubMed ID: 35417176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Stability Constraints in the Particle Engineering of an Inhaled Monoclonal Antibody Dried Powder.
    Brunaugh AD; Ding L; Wu T; Schneider M; Khalaf R; Smyth HDC
    J Pharm Sci; 2022 Feb; 111(2):403-416. PubMed ID: 34453927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
    Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
    Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
    Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
    J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Protein-Excipient Microheterogeneity in Biopharmaceutical Solid-State Formulations by Confocal Fluorescence Microscopy.
    Koshari SH; Ross JL; Nayak PK; Zarraga IE; Rajagopal K; Wagner NJ; Lenhoff AM
    Mol Pharm; 2017 Feb; 14(2):546-553. PubMed ID: 28094996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrostatic spray drying for monoclonal antibody formulation.
    Mutukuri TT; Maa YF; Gikanga B; Sakhnovsky R; Zhou QT
    Int J Pharm; 2021 Sep; 607():120942. PubMed ID: 34324986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spray-Dried and Spray-Freeze-Dried Powder Formulations of an Anti-Interleukin-4Rα Antibody for Pulmonary Delivery.
    Pan HW; Seow HC; Lo JCK; Guo J; Zhu L; Leung SWS; Zhang C; Lam JKW
    Pharm Res; 2022 Sep; 39(9):2291-2304. PubMed ID: 35879500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing freeze drying and spray drying of interleukins using model protein CXCL8 and its variants.
    Fiedler D; Hartl S; Gerlza T; Trojacher C; Kungl A; Khinast J; Roblegg E
    Eur J Pharm Biopharm; 2021 Nov; 168():152-165. PubMed ID: 34474111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Excipients on Freeze-dried Monoclonal Antibody Formulation Degradation and Sub-Visible Particle Formation during Shaking.
    Jin MJ; Ge XZ; Huang Q; Liu JW; Ingle RG; Gao D; Fang WJ
    Pharm Res; 2024 Feb; 41(2):321-334. PubMed ID: 38291165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein inhalation powders: spray drying vs spray freeze drying.
    Maa YF; Nguyen PA; Sweeney T; Shire SJ; Hsu CC
    Pharm Res; 1999 Feb; 16(2):249-54. PubMed ID: 10100310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High concentration formulation feasibility of human immunoglubulin G for subcutaneous administration.
    Dani B; Platz R; Tzannis ST
    J Pharm Sci; 2007 Jun; 96(6):1504-17. PubMed ID: 17387698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry powders for inhalation containing monoclonal antibodies made by thin-film freeze-drying.
    Hufnagel S; Xu H; Sahakijpijarn S; Moon C; Chow LQM; Williams Iii RO; Cui Z
    Int J Pharm; 2022 Apr; 618():121637. PubMed ID: 35259440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of Insoluble Aggregate Formation in a Reconstituted Solution of Spray-Dried Protein Powder.
    Tao Y; Chen Y; Howard W; Ibrahim M; Patel SM; McMahon WP; Kim YJ; Delmar JA; Davis D
    Pharm Res; 2023 Oct; 40(10):2355-2370. PubMed ID: 37131104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.